AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Lagosita M 50mg/1000mg Tablet

Prescription Icon
Prescription Required

Marketer

Max pharma

Salt Composition

Sitagliptin (50mg) + Metformin (1000mg)

Overview Lagosita M 50mg/1000mg Tablet

DiabetaComb 50mg/1000mg tablets combine two medications to manage elevated blood glucose in type 2 diabetes. This dual-action approach helps mitigate severe diabetic complications like renal impairment and vision loss, potentially lessening heart attack or stroke risk. DiabetaComb 50mg/1000mg may be prescribed independently or alongside other antidiabetic therapies. Optimal results require adherence to a balanced diet and regular physical activity. Dosage is tailored to individual needs, considering existing health conditions, blood glucose readings, and concurrent medications. Taking it with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes effectiveness; discontinuation should only occur under physician guidance. Continued commitment to the prescribed diet and exercise regimen is crucial for effective diabetes control. Common side effects include diarrhea, nausea, vomiting, stomach upset, headache, and pharyngitis. Hypoglycemia is a potential risk, especially with concomitant insulin or sulfonylurea use; understanding hypoglycemia recognition and management is essential. This medication isn't suitable for all individuals. Prior to initiating treatment, inform your doctor of any history of kidney, liver, or heart disease, pancreatic issues, or excessive alcohol consumption. Pregnant or lactating individuals must consult their physician. Interactions with other medications are possible; disclose all medications to your doctor to ensure safety. Alcohol should be minimized due to its potential to lower blood glucose. Your doctor will monitor kidney function and blood glucose levels throughout treatment.

Primary Ingredients of Lagosita M 50mg/1000mg Tablet

No text provided. Please provide the text you wish me to rephrase.

Uses of Lagosita M 50mg/1000mg Tablet

Managing Type 2 Diabetes

Major Benefits of Lagosita M 50mg/1000mg Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the Lagosita M 50mg/1000mg tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with a meal.

Common Side effects of Lagosita M 50mg/1000mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Lagosita M 50mg/1000mg Tablet:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the Lagosita M 50mg/1000mg tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with a meal.

How Lagosita M 50mg/1000mg Tablet works:

Lagosita M, a 50mg/1000mg tablet, combines sitagliptin and metformin to manage blood glucose. Sitagliptin boosts insulin production from the pancreas, enhances insulin effectiveness, and lessens hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and improves insulin sensitivity. This dual action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Lagosita M 50mg/1000mg tablets and alcohol is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Lagosita M 50mg/1000mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescription. Seek medical advice before using this medication.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Lagosita M 50mg/1000mg tablets while breastfeeding is likely inadvisable. Preliminary human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by abnormally low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Lagosita M 50mg/1000mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Lagosita M 50mg/1000mg tablets. Physician consultation is recommended. Regular kidney function monitoring is advised during treatment with this medication.

LiverLiverUNSAFE

The use of Lagosita M 50mg/1000mg tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Medical advice is recommended.

What if you forget to take Lagosita M 50mg/1000mg Tablet :

Should you forget a Lagosita M 50mg/1000mg Tablet dose, administer it immediately upon recollection. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Lagosita M 50mg/1000mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Lagosita M 50mg/1000mg Tablet

Lagosita M 50mg/1000mg tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged use of Lagosita M 50mg/1000mg Tablets can lead to vitamin B12 deficiency by impairing its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and urinary issues), and cognitive changes (including balance problems). To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Lagosita M 50mg/1000mg tablets may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Lagosita M 50mg/1000mg Tablets are contraindicated in patients with known allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Lagosita M 50mg/1000mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Lagosita M 50mg/1000mg tablets can cause lactic acidosis (MALA – Metformin-associated lactic acidosis), a serious medical emergency involving high blood lactic acid levels. This rare side effect necessitates avoiding the medication in patients with kidney disease, the elderly, or heavy alcohol users. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea/vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Lagosita M 50mg/1000mg tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Lagosita M 50mg/1000mg tablets may cause common side effects including low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis may occur. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Lagosita M 50mg/1000mg Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Lagosita M 50mg/1000mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Lagosita M 50mg/1000mg Tablets can cause lactic acidosis (MALA – Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect necessitates avoiding the medication in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these symptoms occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Lagosita M 50mg/1000mg tablets can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left unaddressed, may cause anemia, neurological issues such as numbness and tingling in the extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Lagosita M 50mg/1000mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Lagosita M 50mg/1000mg tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Patients with known allergies to Lagosita M 50mg/1000mg Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Lagosita M 50mg/1000mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Lagosita M 50mg/1000mg tablets can cause lactic acidosis (MALA), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect, linked to metformin, necessitates avoidance in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Lagosita M 50mg/1000mg tablets can lead to vitamin B12 deficiency by impairing its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication safely and ensure it remains inaccessible to children, pets, and others.
Lagosita M 50mg/1000mg Ta...
284
MRP 330
13% off